Preparation of composite drug-loaded nanoparticles of carboxyl-chitosan and chitosan modified by glycyrrhizanates
Patent Information
- Authority / Receiving Office
- CN ยท China
- Current Assignee / Owner
- GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
- Publication Date
- 2007-08-01
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to the field of medicine, in particular to a preparation method of glycyrrhizinate-modified chitosan / carboxylated chitosan composite drug-loaded nanoparticles. Background technique
[0002] Nanoparticles (NPs) are solid colloidal particles with a particle size between 10-1000nm that can adsorb and embed various drug molecules. After intravascular injection of nanoparticles, at least 80-85% of NPs were phagocytized by the reticuloendothelial system (RES). They are Kupffer cells, so NPs can accumulate in the liver and have a passive targeting function. The liver is composed of parenchymal cells and non-parenchymal cells (endothelial cells, Kupffer cells, etc.). It contains hundreds of enzymes, and most of the lesions related to the liver, such as liver cancer, hepatitis, and cirrhosis, mostly occur in parenchymal cells. After nanoparticles enter the blood circulation, they are quickly recognized and eliminated by the reticuloendo...